Forsyth Medical Center participating in Avastin trial for new glioblastoma patients

Winston-Salem, N.C. The Derrick L. Davis Forsyth Regional Cancer Center at Forsyth Medical Center is participating in a national trial of the experimental drug Avastin to treat glioblastoma, a fast-growing tumor of the brain or spinal cord. Forsyth Regional Cancer Center (FRCC) is participatin...

Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer

Sutent/Taxol Will Earn Decision Resources' Clinical Gold Standard Status for the Indication by 2012, According to a New Report from Decision Resources WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and hea...

Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017

Unmet Need for Efficacious Therapies for Treating Patients With Mutated KRAS Genes Presents Significant Opportunity for Drug Developers, According to a New Report from Decision Resources WALTHAM, Mass., March 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advis...

Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma

A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme, According to a New Report from Decision Resources WALTHAM, Mass., March 9 /PRNewswire/ -- Deci...

Genentech/Roche/Chugai's Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017

Significant Unmet Need Remains for Agents that are Effective in Treating Triple-Negative Beast Cancer, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and h...

Off-Label Avastin Use for Wet Macular Degeneration

Treatment Could Save Millions Their Sight PORTLAND, Ore., Feb. 25 /PRNewswire/ -- The Food and Drug Administration (FDA) has only approved Avastin for cancer of the colon and lungs. In off-label use, however, Avastin is proving itself as a "miracle drug" that's currently used by...

FDA OKs Avastin for Advanced Breast Cancer

Drug has significant risks, experts say FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration went against the recommendation of its own advisory panel on Friday and approved the cancer drug Avastin for women with advanced breast cancer. The agency cleared the d...

In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer

Following its Approval, Erbitux Will Earn Gold-Standard Status in 2011, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issue...

Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23

Seventy-nine Percent of U.S. Oncologists Currently Use Avastin to Treat the Disease, According to a New Macroview Update from Decision Resources WALTHAM, Mass., Feb. 11 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical an...

Taxol with avastin produces noteworthy results

INDIANAPOLIS The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine. The study with Avastin showed the biggest improvement in metastatic breas...

More>>

Avastin in Medical Technology

New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer

BASEL, Switzerland, Dec. 10 /PRNewswire/ -- New data being presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin (trastuzumab), Avastin (bevacizumab) and oral Xeloda (capecitabine) continue to offer new and better treatment options for breast cancer patients al...

Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer

Despite Widespread Use, Formulary Coverage of Targeted Cancer Therapies is Inconsistent, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issu...

Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer

- Data From Pivotal Phase III AVADO Study Presented at ASCO for the First Time BASEL, Switzerland, May 31 /PRNewswire/ -- Avastin (bevacizumab), significantly improves the time patients with metastatic breast cancer live without their disease getting worse ("pro...

Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer

COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced the initiation of the INTORACT (INvestigation of TORISEL and Avastin Combination Therapy) study, a worldwide randomized, open-label, phase 3b study comparing TORISEL(R)...

Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon

- Tolerability is an Increasingly Important Factor When Selecting Treatment Options for Patients - ABSTRACT No: 5110 (Poster 6H) BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the largest oncology meeting in the world, the American Societ...

Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint

- Results of This Trial Further Confirm the Benefit Avastin Brings to Patients With Breast Cancer. BASEL, Switzerland, Feb. 13 /PRNewswire/ -- Roche announced today that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with ...

Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer

Roche in collaboration with Genentech commit to large phase III adjuvant clinical programme set to unlock Avastin's potential in early breast SAN ANTONIO, Dec. 17 /PRNewswire/ -- According to new phase II study data, Avastin (bevacizumab) can proceed to be tested after breast cancer surgery i...

Wyeth's Torisel and Roche/Genentech's Avastin Will Challenge Pfizer's Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma

Increased Survival Rates and Decreased Disease Progression Rates Are the Advantages, According to a New Report from Decision Resources WALTHAM, Mass., Aug. 7 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and heal...

FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer

ROCKVILLE, Md., April 21, 2007-Genentech and FDA notified healthcare professionals of important new safety information regarding tracheoesophageal (TE) fistula formation in a recent clinical study in patients with limited-stage small cell lung cancer (SCLC). This multicenter, non-randomized, singl...

Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study

EAGAN, Minn.--(BUSINESS WIRE)--Jun 4, 2007 - Imprime PGG(TM), an investigational new drug from Biothera that enhances the innate immune system response, increases the effectiveness of Avastin(R) (bevacizumab) to kill cancer cells, according to new preclinical research presented yesterday at the 200...

Avastin in Medical Dictionary

Common breast

... discuss whether chemicals in our environment have a connection to the risk of breast cancer. ... Common Treatments for Breast Cancer. Arimidex. avastin ... You may sometimes doubt your ability to successfully breast - feed. It is common to have questions and occasional struggles. Remember, mos...

Avastin in Biological News

A crystal ball for brain cancer?

... and predict which ones will be shrunk by the drug avastin -- before the patient ever starts treatment. By l.... Food and Drug Administration approved the use of avastin last month for the treatment of brain cancer. The...ents, like McNabb, are most likely to benefit from avastin before starting a single dose of treatment. The f...

Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems

...VEGF signaling from inside the cell. About 5 percent of patients taking avastin develop blood clot-related side effects, Iruela-Arispe said. But because avastin was approved only three years ago, it is unclear what side effects may occu...

Tiny Tampa Bay fish key to evolution of immune system

...ceptible to enzymes that break them down. A number of such monoclonal antibody-based drugs are in clinical use, such as Herceptin for breast cancer or avastin for colorectal cancer. The lancelet's immune response proteins, however, are resilient. Understanding their essential architecture with such precis...

Scientists discover genetic pathway responsible for breast cancer cell growth

...d to positive clinical results," says Dr. Joseph Ragaz, Director of MUHC Oncology Program. "Evidence-based data on agents such as Gleevac in leukemia, avastin in colorectal cancer, and more recently with Herceptin for breast cancer, confirm that the efforts of researchers like Dr. Giguere and his team save l...

UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders

...CLA research, including Gleevec and the breast cancer drug Herceptin. Additionally, UCLA scientists played key roles in testing the targeted therapies avastin and Tarceva. UCLA also is the only public university in California to boast a sophisticated Good Manufacturing Practice (GMP) suite, a specialized ...

Avastin in Biological Technology

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

...man breast cancer. r84 is distinctive because it selectively blocks VEGF from binding to VEGF receptor 2 (VEGFR2), while non-selective agents such as avastin block binding to both VEGFR2 and VEGF receptor 1 (VEGFR1). Selective anti-VEGF agents such as r84 may have safety and efficacy advantages over non-se...

OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009

...nths and one-year survival rates of 33% to 43%. Market approval for avastin plus paclitaxel and carboplatin chemotherapy for NSCLC was based on...h paclitaxel and carboplatin chemotherapy alone. Survival rates for avastin plus chemotherapy versus chemotherapy alone were reported as 51% ve...

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

... However, Off-Label Use of avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a...ics' Lucentis in Europe. However, off-label use of Genentech/Roche/Chugai's avastin will take market share away from Lucentis from 2012 through 2017 in the Uni...

OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer

... survival rates of 33% to 43%. Market approval for avastin plus paclitaxel and carboplatin chemotherapy for N...reated with chemotherapy alone. Survival rates for avastin plus chemotherapy versus chemotherapy alone were r...dy compares favorably to the survival reported for avastin plus paclitaxel and carboplatin chemotherapy," sai...

AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences

...an Avastin, the current leader in this therapeutic area. A new approach is needed because of increasing data-supported concerns about the high cost of avastin relative to the limited increase in the lifespan of patients gained with its use." Company Profile : AngioGenex, Inc. is actively engaged in th...

Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer

... avastin Used in Combination with Taxol and Paraplatin Will... expert opinion show that Roche/Genentech/Chugai's avastin (bevacizumab) plus the regimen of paclitaxel (Bris...atients with advanced ovarian cancer. As a result, avastin plus paclitaxel/carboplatin will earn a 22 percent...

Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference

...its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law. (1) avastin (TM), a registered trademark of Genentech, Inc Contact: Media Rachel Spielman T: +1-212-583-2714 E: media@rosettagenomics.com Investors Ro...

Biotech Drops Amid Tough Markets in February

...vado, a Phase III study evaluating its cancer drug avastin in combination with docetaxel chemotherapy, met it...sponsored Avado study investigated the addition of avastin administered in two different dosages in combination with chemotherapy. Both doses of avastin in combination with chemotherapy showed "statistic...

Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results

... 23,605 11,099 Total liabilities and shareholders' equity 26,038 $ 13,243 [1] avastin is a registered trademark of Genentech, Inc. Contact: Media Rachel Spielman T: +1-212-583-2714 E: media@rosettagenomics.com Investors Ron Ka...

Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists

...ectly to compounding pharmacies as of January 1. avastin is commonly administered by retinal specialists an... quality. "Many retinal specialists consider the avastin treatment option as an indispensable part of their...continue to meet the critical and ongoing need for avastin in ophthalmologic practice. Unlike other firms, we...